We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Loss of Brain White Matter Increases Stroke Risk

By Biotechdaily staff writers
Posted on 31 Jul 2003
Researchers have established that leukoaraiosis, changes in the brain's white matter that usually occur in the elderly, increases the risk of multiple strokes.

Investigators studied 685 patients aged 34 to 84 years with carotid artery disease who participated in the 2,885-patient North American Symptomatic Carotid Endarterectomy Trial (NASCET) and who had a follow-up computed tomography (CT) scan taken three years or more from entry in the study.

Of the 685 patients in the study, 596 had no leukoaraiosis and 89 had limited white matter. More...
During an average follow-up of 6.1 years, 18% of the 596 patients initially free of leukoaraiosis developed some loss of white matter and 3% had widespread loss. The average age of patients who developed leukoaraiosis was 66.8 years.

The group of patients who developed leukoaraiosis showed a higher tendency to experience at least one stroke: 36% versus 23.5% for the group without leukoaraiosis. After taking gender, age, smoking history, and diseases such as hypertension and diabetes mellitus into consideration, results showed that the patients who developed leukoaraiosis were 1.5 times more likely to have a stroke. The findings were published July 17, 2003, in the online edition of Stroke.

"Patients who developed leukoaraiosis were more likely to have multiple strokes, which generally lead to increased disability, both physically and mentally,” said first author Dr. Jonathan Y. Streifler, director of the neurology unit at the Rabin Medical Center (Petach Tikva, Israel). "These small strokes can be devastating when they hit strategic connections.”

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Portable POCT Blood Gas Analyzer
BD100
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.